Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 51-60 of 2932 for cancer

Edit search filters
  1. Study Of ORIC-114 In Patients With Advanced Solid Tumors Harboring An EGFR Or HER2 Alteration

    Jacksonville, FL, Rochester, MN

  2. A Study Of SGN-CEACAM5C In Adults With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. Study Of EO-3021 In Adult Patients With Solid Tumors Likely To Express CLDN18.2

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study To Investigate ALE.P02 As Monotherapy In Adult Patients With Selected CLDN1+ Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Study Of LY4584180 In Adult Participants With Previously Treated Blood Cancers

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. A Study To Evaluate A Resilient Living Program For Patients With Advancer Cancer And Their Caregivers

    Rochester, MN

  7. Dose Optimization And Expansion Study Of DFV890 In Adult Patients With Myeloid Diseases

    Rochester, MN

  8. A First-in-Human (FIH) Study To Evaluate The Safety And Tolerability Of VVD-130037 In Participants With Advanced Solid Tumors

    Jacksonville, FL, Rochester, MN

  9. A Study Of PF-08052666/​SGN-MesoC2 In Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Study Of NB003 In Patients With Advanced Malignancies

    Jacksonville, FL

.

Mayo Clinic Footer